Increase in human urine homovanillic acid concentration after neuroleptic treatment is the same with or without debrisoquin administration.
Contreras
S A
SA
Maas
J W
JW
Seleshi
E
E
Bowden
C L
CL
D001921:Brain / Q000378:metabolism*; D003647:Debrisoquin / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology / Q000627:therapeutic use*; D006719:Homovanillic Acid / Q000652:urine*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology*; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy
D007546:Isoquinolines; D006220:Haloperidol; D004298:Dopamine; D003647:Debrisoquin; D006719:Homovanillic Acid